Built for today’s labs, the small but mighty #GeneXpert system with touchscreen saves valuable real estate by integrating four standalone accessories into a single touchscreen. Are you ready to save valuable benchtop space? Learn more here: https://ow.ly/vzXq50Ta4kJ
About us
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
- Website
-
http://www.cepheid.com
External link for Cepheid
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Sunnyvale, CA
- Type
- Public Company
- Founded
- 1996
- Specialties
- Molecular Diagnostics, Genetic Testing, Molecular Biology, Infectious Diseases, Cancer, and PCR
Locations
-
Primary
904 Caribbean Drive
Sunnyvale, CA 94089, US
-
Vira Solelh
Maurens-Scopont, 81470, FR
-
Aston Court
Kingsmead Business Park, Frederick Place
High Wycombe, Buckinghamshire HP11 1LA, GB
-
Röntgenv 2
Solna, 171 54, SE
Employees at Cepheid
Updates
-
Each day, over 1 million curable STIs are acquired worldwide.* This World Sexual Health Day, learn more about our Blood Virology, Women’s Health, & Sexual Health testing solutions to aid in detecting #SexualHealth #MolecularDiagnostics *https://ow.ly/VJ3N50T9fie https://ow.ly/uzCh50T9fif
-
Blood cancer is responsible for approximately 6% of all cancer cases, with an estimated 1.24 million cases each year globally.* This Blood Cancer Awareness Month, learn more about our Oncology & Human Genetics testing solutions to aid in detecting nucleophosmin, one of the most common genetic abnormalities in active myeloid leukemia. #MolecularDiagnostics #Oncology *https://ow.ly/HU2B50T9eYs https://ow.ly/oo2K50T9eYq
-
We’re celebrating more than 20 years of innovation at Cepheid by highlighting some of the notable solutions from our past, starting with the SmartCycler® system. The SmartCycler system was the predecessor to the GeneXpert system, combining the amplification and detection phases of nucleic acid testing in one instrument. Fun fact: the SmartCycler system continues to be used on the U.S. space station today! Learn more: https://lnkd.in/e_8BGFBy
-
Being a part of a community of people trusted to deliver actionable results for public health needs means MORE than a Career. It is a commitment to a mission designed to transform diagnostic pathways and enhance patient care. Because every patient matters. #MOREthanacareer
-
Now Available! Xpert® PML-RARA RUO, a quantitative assay for the PML-RARA fusion transcript in EDTA peripheral blood samples. For Research Use Only. Not for use in diagnostic procedures. #MolecularDiagnostics #Oncology Learn more: https://ow.ly/aGrP50T7HM6
-
Today, we're proud to commemorate the 20th anniversary of Cepheid’s Bothell, Washington site, founded in 2004 by Alexander Gall. The founding researchers were a small team with a deep understanding of the chemistry to create leading PCR products. Today, the Bothell site has over 150 employees and provides important reagents needed at Cepheid sites worldwide. It’s about providing more answers to more people everywhere. #MolecularDiagnostics #BestTeamWins
-
Vaginitis is complicated, but it doesn’t need to be... There’s A Better Way. Real-world data study of >4M females shows significant clinical burden of vaginitis symptoms in the U.S. The poster presented at IDSOG — Portland, OR showed that <25% of non-pregnant people had a documented vaginitis test upon symptom presentation. The study suggested an unmet need to improve vaginitis diagnosis to reduce empiric treatment. #SexualHealth See full poster here: https://ow.ly/ahtr50SWeTu
Affiliated pages
Similar pages
Browse jobs
Stock
DHR
NYSE
20 minutes delay
$273.09
6.89 (2.588%)
- Open
- 267.62
- Low
- 266.28
- High
- 273.18
Data from Refinitiv
See more info on